Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.stoketherapeutics.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3 Preston Court, Suite 102, MA, 01730
Bedford
United States
Email
Contact Number
+1 781-430-8200

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/stoke-therapeutics” connections=”true” suffix=””]